The American Journal of Medicine
Volume 123, Issue 9 , Pages 847-855, September 2010

Management and Outcomes of Renal Disease and Acute Myocardial Infarction

  • Paul A. Santolucito, MD

      Affiliations

    • Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Mass
  • ,
  • Dennis A. Tighe, MD

      Affiliations

    • Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Mass
  • ,
  • David D. McManus, MD

      Affiliations

    • Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Mass
  • ,
  • Jorge Yarzebski, MD, MPH

      Affiliations

    • Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Mass
  • ,
  • Darleen Lessard, MS

      Affiliations

    • Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Mass
  • ,
  • Joel M. Gore, MD

      Affiliations

    • Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Mass
  • ,
  • Robert J. Goldberg, PhD

      Affiliations

    • Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Mass
    • Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Mass
    • Corresponding Author InformationRequests for reprints should be addressed to Robert J. Goldberg, PhD, Division of Epidemiology, Department of Quantitative Health Sciences, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655

Abstract 

Background

Contemporary trends in the management and outcomes of chronic kidney disease patients who develop an acute myocardial infarction have not been adequately described, particularly from the more generalizable perspective of a population-based investigation.

Methods

The study population consisted of 6219 residents of the Worcester, Massachusetts, metropolitan area who were hospitalized with acute myocardial infarction in 6 annual periods between 1995 and 2005. Patients were categorized as having preserved kidney function (n=3154), mild to moderate chronic kidney disease (n=2313), or severe chronic kidney disease (n=752) at the time of hospital admission.

Results

Patients with chronic kidney disease were more likely to be older, to have a greater prevalence of comorbidities, and to experience significant in-hospital complications or die during hospitalization in comparison with patients with preserved kidney function. Although patients with chronic kidney disease were less likely to receive effective cardiac medications or undergo coronary interventional procedures than patients without kidney disease, we observed a marked increase in the use of effective cardiac medications and coronary interventional procedures in patients with chronic kidney disease during the period under study. In-hospital death rates declined over time among patients with chronic kidney disease, whereas these death rates remained unchanged among persons with normal kidney function.

Conclusion

The results of this study in residents of a large New England metropolitan area provide insights into changing trends in the treatment and impact of chronic kidney disease in patients hospitalized with acute myocardial infarction.

Keywords: Acute myocardial infarction, Long-term trends and outcomes, Population-based study, Renal disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Funding:National Institutes of Health (RO1 HL35434).

 Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(10)00462-6

doi:10.1016/j.amjmed.2010.04.025

The American Journal of Medicine
Volume 123, Issue 9 , Pages 847-855, September 2010